Mediar Therapeutics is planning to launch a Phase 2 clinical trial in the first half of 2025 to test its IPF therapy MTX-463.

The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.

Broadway performers will sing show tunes at the 15th annual Pulmonary Fibrosis Foundation Broadway Belts for PFF! event, which will be held at New York’s Sony Hall March 10 to raise funds and ...